GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds
- Posted on March 2, 2026
- By The Independent
- 3 Views
GLP-1 weight loss drugs could increase risk of osteoporosis and gout, new research finds
Taking popular GLP-1 class weight loss drugs like Ozempic and Wegovy could be linked to a higher risk of developing osteoporosis, gout and a condition that causes severe bone softening compared to people who don’t use the medications, researchers said Monday.
